Startups & Founders often underestimate a simple reality — investors do their homework quietly. Before they reply to an intro email, before they accept a LinkedIn request, and sometimes even before opening your pitch deck, they visit your website.
Startups & Founders often underestimate a simple reality — investors do their homework quietly. Before they reply to an intro email, before they accept a LinkedIn request, and sometimes even before opening your pitch deck, they visit your website.
French MedTech company FineHeart, which develops advanced cardiovascular implantable devices, has secured a total of €83 million in funding through a combination of equity financing and European public grants.
In the global tech arena, where unicorns often emerge from Silicon Valley or megacities in Asia, Markus Villig represents a different kind of founder. Quietly determined, deeply pragmatic, and firmly rooted in his home country, he built Bolt into one of the world’s leading mobility platforms—starting with little more than
Seattle-based AI commerce startup Spangle, founded by former Bolt CEO Maju Kuruvilla, has raised $15 million in a Series A round, pushing the company’s post-money valuation to $100 million.
London-based biotech company Engitix has raised €21 million ($25 million) in a Series A extension to advance its work on therapies targeting the extracellular matrix (ECM) in cancer and fibrotic diseases.
BrightHeart, a Paris-based MedTech company developing artificial intelligence software for prenatal ultrasound, has closed an €11 million Series A financing round. The investment will support U.S. market entry, continued expansion across Europe, and further development of its AI platform for expert-level fetal screening.
Belgium-based legaltech startup Alice has raised €1 million in pre-seed funding to further develop its AI-driven platform for professional legal casework.
United Manufacturing Hub has secured €5 million in new funding to accelerate the development of its open-source platform designed to unify and standardise factory data.
Vitrealab, a Vienna-based deeptech company developing photonic integrated circuits for augmented reality displays, has raised €9.4 million ($11 million) in a Series A financing round. The capital will be used to advance and industrialise the company’s Quantum Light Chip technology designed for next-generation AR glasses.
Biographica, a London-based agricultural biotechnology company, has secured £7 million in new funding to accelerate the global rollout of its AI-powered crop design platform.
